The Serine Protease Inhibitor Camostat Mesilate Attenuates the Progression of Chronic Kidney Disease through its Antioxidant Effects

Publisher： Karger

E-ISSN： 2235-3186|129|3|223-232

ISSN： 1660-8151

Source： Nephron, Vol.129, Iss.3, 2015-03, pp. : 223-232

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Trial for the Treatment of Steroid Dependency in Minimal Change Disease: Combined Therapy of Camostat Mesilate and Glycyrrhizin

By  

Nephron, Vol. 90, Iss. 3, 2002-02 ,pp. : 357-360

Karger

Access to resources Recommend Favorite

Sex Differences in the Prevalence, Progression, and Improvement of Chronic Kidney Disease

By  

Kidney and Blood Pressure Research, Vol. 39, Iss. 4, 2014-08 ,pp. : 279-288

Karger

Access to resources Recommend Favorite

A Nexus of Progression of Chronic Kidney Disease: Charcoal, Tryptophan and Profibrotic Cytokines

By  

Blood Purification, Vol. 24, Iss. 1, 2005-12 ,pp. : 143-148

Karger

Access to resources Recommend Favorite

Hydration and Chronic Kidney Disease Progression: A Critical Review of the Evidence

By  

American Journal of Nephrology, Vol. 43, Iss. 4, 2016-05 ,pp. : 281-292

Karger

Access to resources Recommend Favorite

Is Insulin Resistance a Risk Factor for the Progression of Chronic Kidney Disease?

By  

Kidney and Blood Pressure Research, Vol. 34, Iss. 2, 2011-02 ,pp. : 111-115

Karger

Access to resources Recommend Favorite